Serum lactate dehydrogenase is a more useful biomarker of prognosis than serum S100B in patients with BRAF-mutant melanoma.
Center for Melanoma, Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA, 02114, U.S.A.. rsullivan7@mgh.harvard.edu.
R J
RJ
Sullivan
D015415:Biomarkers; D014408:Biomarkers, Tumor / Q000097:blood; D006801:Humans; D045022:Lactate Dehydrogenases; D008545:Melanoma / Q000097:blood*; D009414:Nerve Growth Factors / Q000097:blood; D011379:Prognosis; D009418:S100 Proteins / Q000097:blood
D015415:Biomarkers; D014408:Biomarkers, Tumor; D009414:Nerve Growth Factors; D009418:S100 Proteins; D045022:Lactate Dehydrogenases